Role of sevoflurane in myocardial ischemia-reperfusion injury via the ubiquitin-specific protease 22/lysine-specific demethylase 3A axis

References

• Soares ROS, Losada DM, Jordani MC, et al. Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies. Int J Mol Sci. 2019;20:5034.
   PubMed Web of Science ®Google Scholar
• Xia Z, Li H, Irwin MG. Myocardial ischaemia reperfusion injury: the challenge of translating ischaemic and anaesthetic protection from animal models to humans. Br J Anaesth. 2016;117(Suppl 2):ii44–ii62.
   PubMed Web of Science ®Google Scholar
• Ibanez B, Heusch G, Ovize M, et al. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65:1454–1471.
   PubMed Web of Science ®Google Scholar
• Lejay A, Fang F, John R, et al. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. J Mol Cell Cardiol. 2016;91:11–22.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Balla C, Malagu M, et al. Reperfusion damage- a story of success, failure, and hope. Circ J. 2017;81:131–141.
   PubMed Web of Science ®Google Scholar
• Barzegar M, Kaur G, Gavins FNE, et al. Potential therapeutic roles of stem cells in ischemia-reperfusion injury. Stem Cell Res. 2019;37:101421.
   PubMed Web of Science ®Google Scholar
• Li J, Liu P, Li H, et al. Sevoflurane preconditioning prevents septic myocardial dysfunction in lipopolysaccharide-challenged mice. J Cardiovasc Pharmacol. 2019;74:462–473.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu P, Hua F, et al. Sevoflurane postconditioning reduces myocardial ischemia reperfusion injury-induced necroptosis by up-regulation of OGT-mediated O-GlcNAcylated RIPK3. Aging (Albany NY). 2020;12:25452–25468.
   PubMedGoogle Scholar
• Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159–192.
   PubMed Web of Science ®Google Scholar
• Ma S, Sun L, Wu W, et al. USP22 protects against myocardial ischemia-reperfusion injury via the SIRT1-p53/SLC7A11-dependent inhibition of ferroptosis-induced cardiomyocyte death. Front Physiol. 2020;11:551318.
   PubMed Web of Science ®Google Scholar
• Keren I, Lapidot M, Citovsky V. Coordinate activation of a target gene by KDM1C histone demethylase and OTLD1 histone deubiquitinase in Arabidopsis. Epigenetics. 2019;14:602–610.
   PubMed Web of Science ®Google Scholar
• Papait R, Serio S, Pagiatakis C, et al. Histone methyltransferase G9a is required for cardiomyocyte homeostasis and hypertrophy. Circulation. 2017;136:1233–1246.
   PubMed Web of Science ®Google Scholar
• Zhang BF, Jiang H, Chen J, et al. LncRNA H19 ameliorates myocardial infarction-induced myocardial injury and maladaptive cardiac remodelling by regulating KDM3A. J Cell Mol Med. 2020;24:1099–1115.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu R, Zhang L, et al. Downregulation of miR-335 exhibited an oncogenic effect via promoting KDM3A/YAP1 networks in clear cell renal cell carcinoma. Cancer Gene Ther. 2021. DOI:10.1038/s41417-021-00335-3
   Web of Science ®Google Scholar
• Wang HY, Long QY, Tang SB, et al. Histone demethylase KDM3A is required for enhancer activation of hippo target genes in colorectal cancer. Nucleic Acids Res. 2019;47:2349–2364.
   PubMed Web of Science ®Google Scholar
• Zhu X, Li S, Huang C, et al. LncRNA CRNDE inhibits cardiomyocytes apoptosis by YAP1 in myocardial ischaemia/reperfusion injury. Autoimmunity. 2021;54:204–212.
   PubMed Web of Science ®Google Scholar
• Jones-Bolin S. Guidelines for the care and use of laboratory animals in biomedical research. Curr Protoc Pharmacol. 2012;Appendix 4: Appendix 4B.
   PubMedGoogle Scholar
• Tan DX, Chen XX, Bai TZ, et al. Sevoflurane up-regulates microRNA-204 to ameliorate myocardial ischemia/reperfusion injury in mice by suppressing Cotl1. Life Sci. 2020;259:118162.
   PubMed Web of Science ®Google Scholar
• Qi Z, Li S, Su Y, et al. Role of microRNA-145 in protection against myocardial ischemia/reperfusion injury in mice by regulating expression of GZMK with the treatment of sevoflurane. J Cell Physiol. 2019;234:16526–16539.
   PubMed Web of Science ®Google Scholar
• Xu LJ, Chen RC, Ma XY, et al. Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation. Phytomedicine. 2020;68:153169.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Lei S, Zhao B, et al. NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats. Oxid Med Cell Longev. 2017;2017:9743280.
   PubMed Web of Science ®Google Scholar
• Gao S, Wang R, Dong S, et al. Inactivation of TOPK caused by hyperglycemia blocks diabetic heart sensitivity to sevoflurane postconditioning by impairing the PTEN/PI3K/Akt signaling. Oxid Med Cell Longev. 2021;2021:6657529.
   PubMed Web of Science ®Google Scholar
• Chen J, Li X, Zhao F, et al. HOTAIR/miR-17-5p axis is involved in the propofol-mediated cardioprotection against ischemia/reperfusion injury. Clin Interv Aging. 2021;16:621–632.
   PubMed Web of Science ®Google Scholar
• Ren L, Chen S, Liu W, et al. Downregulation of long non-coding RNA nuclear enriched abundant transcript 1 promotes cell proliferation and inhibits cell apoptosis by targeting miR-193a in myocardial ischemia/reperfusion injury. BMC Cardiovasc Disord. 2019;19:192.
   PubMed Web of Science ®Google Scholar
• Xiao X, Lu Z, Lin V, et al. MicroRNA miR-24-3p reduces apoptosis and regulates Keap1-Nrf2 pathway in mouse cardiomyocytes responding to ischemia/reperfusion injury. Oxid Med Cell Longev. 2018;2018:7042105.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wu X, Yang J. miR-194-5p protects against myocardial ischemia/reperfusion injury via MAPK1/PTEN/AKT pathway. Ann Transl Med. 2021;9:654.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Huang X, Zhang Z, et al. USP15 enhances re-epithelialization through deubiquitinating EIF4A1 during cutaneous wound repair. Front Cell Dev Biol. 2020;8:529.
   PubMed Web of Science ®Google Scholar
• Gao R, Buechel D, Kalathur RKR, et al. USP29-mediated HIF1alpha stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis. Oncogenesis. 2021;10:52.
   PubMed Web of Science ®Google Scholar
• Zhang R, Li Y, Liu X, et al. FOXO3a-mediated long non-coding RNA LINC00261 resists cardiomyocyte hypoxia/reoxygenation injury via targeting miR23b-3p/NRF2 axis. J Cell Mol Med. 2020;24:8368–8378.
   PubMed Web of Science ®Google Scholar
• Chang L, Wang Q, Ju J, et al. Magnoflorine ameliorates inflammation and fibrosis in rats with diabetic nephropathy by mediating the stability of lysine-specific demethylase 3A. Front Physiol. 2020;11:580406.
   PubMed Web of Science ®Google Scholar
• Cai Y, Fu X, Deng Y. Histone demethylase JMJD1C regulates esophageal cancer proliferation via YAP1 signaling. Am J Cancer Res. 2017;7:115–124.
   PubMed Web of Science ®Google Scholar
• Frank A, Bonney M, Bonney S, et al. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth. 2012;16:123–132.
   PubMedGoogle Scholar
• Xie H, Zhang J, Zhu J, et al. Sevoflurane post-conditioning protects isolated rat hearts against ischemia-reperfusion injury via activation of the ERK1/2 pathway. Acta Pharmacol Sin. 2014;35:1504–1513.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim MS, Shin JM, et al. The expression patterns of deubiquitinating enzymes, USP22 and Usp22. Gene Expr Patterns. 2006;6:277–284.
   PubMed Web of Science ®Google Scholar
• De Hert S, Moerman A. Sevoflurane. F1000Res. 2015;4:626.
   PubMedGoogle Scholar
• Lu Y, Bu M, Yun H. Sevoflurane prevents hypoxia/reoxygenation-induced cardiomyocyte apoptosis by inhibiting PI3KC3-mediated autophagy. Hum Cell. 2019;32:150–159.
   PubMed Web of Science ®Google Scholar
• Cao J, Xie H, Sun Y, et al. Sevoflurane post-conditioning reduces rat myocardial ischemia reperfusion injury through an increase in NOS and a decrease in phopshorylated NHE1 levels. Int J Mol Med. 2015;36:1529–1537.
   PubMed Web of Science ®Google Scholar
• Kortekaas KA, van der Baan A, Aarts LP, et al. Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repair. Br J Anaesth. 2014;112:1005–1014.
   PubMed Web of Science ®Google Scholar
• Yao YT, Fang NX, Shi CX, et al. Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Chin Med J (Engl). 2010;123:1320–1328.
   PubMed Web of Science ®Google Scholar
• Lu H, Liufu N, Dong Y, et al. Sevoflurane acts on ubiquitination-proteasome pathway to reduce postsynaptic density 95 protein levels in young mice. Anesthesiology. 2017;127:961–975.
   PubMed Web of Science ®Google Scholar
• Hu C, Tian Y, Xu H, et al. Inadequate ubiquitination-proteasome coupling contributes to myocardial ischemia-reperfusion injury. J Clin Invest. 2018;128:5294–5306.
   PubMed Web of Science ®Google Scholar
• Roedig J, Kowald L, Juretschke T, et al. USP22 controls necroptosis by regulating receptor-interacting protein kinase 3 ubiquitination. EMBO Rep. 2021;22:e50163.
   PubMed Web of Science ®Google Scholar
• Xu S, Wu B, Zhong B, et al. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered. 2021;12:10924–10934.
   PubMed Web of Science ®Google Scholar
• Hong A, Lee JE, Chung KC. Ubiquitin-specific protease 22 (USP22) positively regulates RCAN1 protein levels through RCAN1 de-ubiquitination. J Cell Physiol. 2015;230:1651–1660.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen J, Zhang B, et al. KDM3A inhibition modulates macrophage polarization to aggravate post-MI injuries and accelerates adverse ventricular remodeling via an IRF4 signaling pathway. Cell Signal. 2019;64:109415.
   PubMed Web of Science ®Google Scholar
• Zhang QJ, Tran TAT, Wang M, et al. Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis. Nat Commun. 2018;9:5230.
   PubMed Web of Science ®Google Scholar
• Herzog M, Josseaux E, Dedeurwaerder S, et al. The histone demethylase Kdm3a is essential to progression through differentiation. Nucleic Acids Res. 2012;40:7219–7232.
   PubMed Web of Science ®Google Scholar
• Lin H, Zhu X, Chen G, et al. KDM3A-mediated demethylation of histone H3 lysine 9 facilitates the chromatin binding of Neurog2 during neurogenesis. Development. 2017;144:3674–3685.
   PubMed Web of Science ®Google Scholar
• Yu Y, Su X, Qin Q, et al. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases. Pharmacol Res. 2020;159:105009.
   PubMed Web of Science ®Google Scholar
• Khan K, Makhoul G, Yu B, et al. The cytoprotective impact of yes-associated protein 1 after ischemia-reperfusion injury in AC16 human cardiomyocytes. Exp Biol Med. 2019;244:802–812.
   PubMed Web of Science ®Google Scholar